VUZE Medical
Software-only Guidance Solution for Spinal Surgery
Startup Seed Health Tech & Life Sciences Est. 2017
Total Raised
Undisclosed
Seed
Last Round
Undisclosed
1 rounds
Investors
1
1 public
Team
2
1-10 employees
Confidence
90/100
News
3
articles
Patents
1
About
Vuze Medical is the developer of VUZE, a software-only intra-operative guidance solution for skeletal surgery with a focus on the spine. VUZE targets the ongoing migration to ambulatory settings in an effort to lower healthcare costs and increase patient comfort. VUZE is also designed for populous, cost-conscious economies experiencing a rapid growth in surgical volume. VUZE serves growing market segments in which current computer-assisted surgery (CAS) is deemed less suitable. The solution offers an improvement over commonly used X-ray guidance by relieving the primary pain points of accuracy and radiation exposure. Using its proprietary dynamic online image fusion software technology, VUZE automatically and in real time overlays the positions and forward trajectories of surgical tools seen in standard in-surgery 2D X-rays onto a standard presurgery 3D scan. The only additional hardware required in the operating room is a PC for running the VUZE software. VUZE aims to maintain the simplicity, affordability, and (software-controlled) tool neutrality of current X-ray guidance while enabling greater accuracy and far fewer X-rays.
Classification
Sector
Health Tech & Life SciencesDigital HealthcareMedical Decision Support
Core Technology
Platforms & InterfacesSoftware
Target Customer
Healthcare & Life SciencesHealthcareProviders
Business Model
B2B
Tags
navigationx-ray3d-technologyhospitalssoftware-platformdigital-healthcarereal-timeimagingsurgerypatent-pending
Funding & Events
Jul 2019
Seed Undisclosed
Welltech Ventures
News (3)
Oct 9, 2023 · www.businesswire.com
VUZE Medical to Showcase Next Generation Software-based Guidance System for Spine Surgery at NASS 2023 Following FDA Filing
May 12, 2023 · www.odtmag.com
Growth-Positive
VUZE Surgical Guidance System Shows Promise in Clinical Study
Customers
Jan 17, 2022 · www.businesswire.com
VUZE Medical Announces U.S. FDA 510(k) Clearance for Its VUZE System
Details
Product Stage
Clinical Trial
Employees
1-10
Exact Count
10
District
Center District
Founded
2017
Registrar
515623064
Locations
Zarhin St 13, Ra'anana, Israel
Links
Website
LinkedIn
Admin
Last Update
Jan 7, 2025
Verified by
Maor Perlov
Missing
markets, not claimed
Team (2)
David Tolkowsky
Founder & CEO
Founder
Ran (Ranco) Cohen
CTO
Internal
Created by
Yotam Maman (yotamm1988@gmail.com)
Created
2020-07-07T00:00:00.000Z
Last editor
Yanina Wainscheinker (yanina.wainscheinker@sncentral.org)